Optometrists in Grayling, MI Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Kelly Jean Drake, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 E Michigan Ave, Grayling, MI 49738 Phone: 989-348-2833 Fax: 989-843-2834 |
 Alpine Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1200 N Down River Rd, Grayling, MI 49738 Phone: 989-348-8689 Fax: 989-348-6462 |
 Dr. Robert A Aubry, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 904 E Michigan Ave, Grayling, MI 49738 Phone: 989-348-3211 Fax: 989-348-7852 |
Dr. William I Dean, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 904 E Michigan Ave, Grayling, MI 49738 Phone: 989-348-3211 Fax: 989-348-7852 |
Grayling Eye Care, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 E Michigan Ave, Grayling, MI 49738 Phone: 989-348-2833 Fax: 989-348-3824 |
Ausable Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 904 E Michigan Ave, Grayling, MI 49738 Phone: 989-348-3211 Fax: 989-348-7852 |
News Archive
Clinical evaluation of benzodiazepine products is now allowed using Acura's Aversion Technology
Acura Pharmaceuticals, Inc. today announced clinical evaluation is now allowed under an Investigational New Drug application ("IND") filed with the U.S. Food and Drug Administration ("FDA") for a benzodiazepine product candidate utilizing our Aversion® Technology.
New article highlights positive impact of the BFHI on breastfeeding outcomes
The 10-step Baby-Friendly Hospital Initiative, aimed at promoting breastfeeding initiation and exclusivity to improve early infant health in the U.S. is having a positive impact on some measures, but others have proven more challenging to influence or assess.
Human bird flu suspects in Malaysia quarantined
Health officials in Malaysia say two people have been quarantined in Malaysian hospitals with suspected bird flu and health officials are also looking into the suspected case in an elderly patient in the state of Selangor.
Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer
Updated results of a Phase III study of Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, show everolimus provided additional time women with advanced breast cancer lived without their disease progressing.
› Verified 2 days ago
Physical Therapists
Chiropractors
Optometrists
Occupational Therapists
Podiatrists
Audiologists